Cancer cells forgo translating mRNA transcribed from genes of nonspecialized tasks

Mahmoud Ahmed1, Trang Minh Pham1, Hyun Joon Kim2

  • 1Department of Biochemistry and Convergence Medical Sciences, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, South Korea.

FEBS Open Bio
|March 11, 2024
PubMed

Insights

Cancer cells may prioritize gene expression over protein production for certain functions, a trade-off impacting cell division and drug response.

Area of Science:

  • Molecular Biology
  • Cancer Cell Biology
  • Systems Biology

Background:

  • Prokaryotes couple transcription and translation for mRNA regulation.
  • Eukaryotes utilize distinct mechanisms for gene expression control.
  • Understanding gene and protein level disparities is crucial in cancer research.

Purpose of the Study:

  • To quantify the discrepancy between gene expression and protein levels in breast cancer cells.
  • To investigate the origins of these disparities, particularly in relation to cancer hallmarks.
  • To correlate these differences with cell division rates and drug responses.

Main Methods:

  • Utilized publicly available data on gene expression, protein levels, division rate, and drug-induced growth inhibition.
  • Analyzed breast cancer cell lines with shared origins but different evolutionary paths.
  • Examined resource allocation to specific cellular tasks, including cancer hallmarks, at transcriptional and translational levels.

Main Results:

  • Observed variable mRNA-protein correlation across cell lines, higher for cancer hallmark gene products.
  • Found that differences in gene- and protein-based enrichment correlated with cell division rates but not drug-induced growth inhibition.
  • Noted a wider range of protein synthesis enrichment compared to gene transcription enrichment within cells.

Conclusions:

  • Cancer cells may strategically under-translate certain genes, potentially conserving resources or adapting to stress.
  • This trade-off between gene expression and protein production influences cell division and response to drug treatments.
  • The differential enrichment of hallmark genes and proteins offers insights into cancer cell adaptation and survival strategies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K